Khashab MA, Emerson RE, DeWitt JM. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of anaplastic pancreatic carcinoma: a single-center experience. Pancreas. 2010;39:88–91.

Article  PubMed  Google Scholar 

Chadha MK, LeVea C, Javle M, et al. Anaplastic pancreatic carcinoma: a case report and review of literature. JOP. 2004;5:512–5.

PubMed  Google Scholar 

Sakaguchi K, Kuroda Y, Sugo H, et al. Spindle cell type anaplastic carcinoma of the pancreas: review of 27 Japanese case reports. Nihon Shokakibyo Gakkai Zasshi. 2020;117:430–6.

PubMed  Google Scholar 

Clark CJ, Graham RP, Arun JS, et al. Clinical outcomes for anaplastic pancreatic cancer: a population-based study. J Am Coll Surg. 2012;215:627–34.

Article  PubMed  Google Scholar 

Paal E, Thompson LD, Frommelt RA, et al. A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. Ann Diagn Pathol. 2001;5:129–40.

Article  PubMed  CAS  Google Scholar 

Strobel O, Hartwig W, Bergmann F, et al. Anaplastic pancreatic cancer: presentation, surgical management, and outcome. Surgery. 2011;149:200–8.

Article  PubMed  Google Scholar 

Hoshimoto S, Matsui J, Miyata R, et al. Anaplastic carcinoma of the pancreas: case report and literature review of reported cases in Japan. World J Gastroenterol. 2016;22:8631–7.

Article  PubMed  PubMed Central  Google Scholar 

Kowalewski A, Szylberg Ł, Saganek M, et al. Emerging strategies in BRCA-positive pancreatic cancer. J Cancer Res Clin Oncol. 2018;144:1503–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Leung K, Saif MW. BRCA-associated pancreatic cancer: the evolving management. JOP. 2013;14:149–51.

PubMed  Google Scholar 

Rosen MN, Goodwin RA, Vickers MM. BRCA mutated pancreatic cancer: a change is coming. World J Gastroenterol. 2021;27:1943–58.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Golan T, Kanji ZS, Epelbaum R, et al. Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers. Br J Cancer. 2014;111:1132–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Japan Pancreas Society. Pancreatic cancer registry report. Suizo. 2007;22:e26–8.

Yang G, Yin J, Ou K, et al. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas harboring KRAS and BRCA mutations: case report and whole exome sequencing analysis. BMC Gastroenterol. 2020;20:202.

Article  PubMed  PubMed Central  Google Scholar 

Kindler HL, Hammel P, Reni M, et al. Overall survival results from the POLO trial: a phase III study of active maintenance Olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer. J Clin Oncol. 2022;40:3929–39.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang-Gillam A, Li C-P, Bodoky G, et al. Nanoliposomal Irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet. 2016;387:545–57.

Article  PubMed  CAS  Google Scholar 

Cornish AJ, Gruber AJ, Kinnersley B, et al. The genomic landscape of 2,023 colorectal cancers. Nature. 2024;633:127–36.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Smeby J, Kryeziu K, Berg KCG, et al. Molecular correlates of sensitivity to PARP Inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity. EBioMedicine. 2020;59:102923.

Article  PubMed  PubMed Central  CAS  Google Scholar